FFF Enterprises Announces Addition to National Accounts Team

December 1, 2005 Media Release

Biopharmaceutical supply channel innovator receives U.S. distribution deal

TEMECULA, Calif. - FFF Enterprises Inc., a healthcare corporation based in Temecula, Calif., announced today the appointment of Whitney Stuart to fill a new role within its sales leadership, vice president of national accounts. A respected industry veteran, Stuart will work closely with FFF's group purchasing organization (GPO) customers and manufacturer partners.

Stuart spent most of the last six years with the American Red Cross, as the national director of corporate accounts. She negotiated contracts with GPOs, acute care and alternate site providers; provided guidance to ARC's sales and marketing teams; and had responsibility for the launch, brand awareness and channel management of ARC's plasma products.

"We are very pleased to add Whitney to our team of seasoned healthcare professionals," said Chris Ground, FFF's senior vice president of national accounts. "We worked with Whitney during her tenure at ARC, and developed a deep respect for her understanding of the entire marketplace, from patient to manufacturer. And now, she brings to FFF a comprehensive and caring appreciation for our GPO customers that will enhance our ongoing dedication to excellent relationships with them."

FFF, the nation's largest distributor of plasma products, manages and distributes biopharmaceuticals and vaccines, and has created some of the industry's leading supply innovations, including the nation's first electronic drug pedigree system.

"I have been impressed by FFF's ability to continually satisfy customer needs, despite volatile market dynamics," said Stuart, "and I respect the company's unwavering passion for being the best, most reliable source of plasma products for the patient communities that it serves. I look forward to contributing to our vision as FFF continues to grow."

Before joining the American Red Cross, Stuart was employed in the biotechnology industry by Digene Corporation, where she managed the U.S. launch of the company's gene-based hybrid capture detection assay for the detection of HPV, CMV, HBV and other viral agents. She received an MBA from George Washington University in Washington, DC, and earned a Bachelor of Science in Biology from the University of Tennessee.

Stuart can be reached at wstuart@fffenterprises.com.

About FFF Enterprises
FFF Enterprises was founded in 1988 and has since grown into a multidimensional healthcare company, delivering innovative solutions in biopharmaceutical management and distribution, health information management and consumer healthcare services. FFF is now the nation's largest supplier of human plasma products and vaccines, and also distributes other biopharmaceuticals and clinical trial drugs. Customers of FFF's four divisions include members of the leading U.S. acute care and non-acute care group purchasing organizations, pharmaceutical manufacturers, biotech companies, contract research organizations, managed healthcare and consumers. FFF's unique distribution business model has institutionalized Guaranteed Channel Integrity™, which reflects the company's commitment to purchase only from manufacturers and ship only to healthcare providers - one clear line with no gray in between. This protects products from secondary and gray markets, and improves patient safety.